These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1653645)

  • 1. Effect of angiotensin converting enzyme inhibition on the incidence of restenosis after percutaneous transluminal coronary angioplasty.
    Brozovich FV; Morganroth J; Gottlieb NB; Gottlieb RS
    Cathet Cardiovasc Diagn; 1991 Aug; 23(4):263-7. PubMed ID: 1653645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
    Circulation; 1992 Jul; 86(1):100-10. PubMed ID: 1535568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetic analysis of the effect of angiotensin-converting enzyme inhibitor on restenosis after percutaneous transluminal coronary angioplasty.
    Okamura A; Ohishi M; Rakugi H; Katsuya T; Yanagitani Y; Takiuchi S; Taniyama Y; Moriguchi K; Ito H; Higashino Y; Fujii K; Higaki J; Ogihara T
    Angiology; 1999 Oct; 50(10):811-22. PubMed ID: 10535720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of cardiac function by angiotensin converting enzyme inhibition. Sites of action.
    Dietz R; Waas W; Süsselbeck T; Willenbrock R; Osterziel KJ
    Circulation; 1993 May; 87(5 Suppl):IV108-16. PubMed ID: 8485825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of restenosis after coronary angioplasty.
    Samani NJ; Martin DS; Brack M; Cullen J; Chauhan A; Lodwick D; Harley A; Swales JD; de Bono DP; Gershlick AH
    Lancet; 1995 Apr; 345(8956):1013-6. PubMed ID: 7723497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme and apolipoprotein E genotypes and restenosis after coronary angioplasty.
    van Bockxmeer FM; Mamotte CD; Gibbons FA; Burke V; Taylor RR
    Circulation; 1995 Oct; 92(8):2066-71. PubMed ID: 7554183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between angiotensin converting enzyme gene polymorphism, coronary artery disease, and stent restenosis: the role of angiotensin converting enzyme inhibitors in stent restenosis in patients with diabetes mellitus.
    Guneri S; Baris N; Aytekin D; Akdeniz B; Pekel N; Bozdemir V
    Int Heart J; 2005 Sep; 46(5):889-97. PubMed ID: 16272779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of coronary in-stent restenosis: importance of angiotensin-converting enzyme gene polymorphism and treatment with angiotensin-converting enzyme inhibitors.
    Jørgensen E; Kelbaek H; Helqvist S; Jensen GV; Saunamäki K; Kastrup J; Havndrup O; Bundgaard H; Kyst Madsen J; Christiansen M; Andersen PS; Reiber JH
    J Am Coll Cardiol; 2001 Nov; 38(5):1434-9. PubMed ID: 11691520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation between the deletion polymorphism of the angiotensin-converting enzyme gene and late luminal narrowing after coronary angioplasty.
    Hamon M; Bauters C; Amant C; McFadden EP; Helbecque N; Lablanche JM; Bertrand ME; Amouyel P
    Circulation; 1995 Aug; 92(3):296-9. PubMed ID: 7634441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme inhibition with fosinopril sodium in the prevention of restenosis after coronary angioplasty.
    Desmet W; Vrolix M; De Scheerder I; Van Lierde J; Willems JL; Piessens J
    Circulation; 1994 Jan; 89(1):385-92. PubMed ID: 8281674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty.
    Tsuchikane E; Fukuhara A; Kobayashi T; Kirino M; Yamasaki K; Kobayashi T; Izumi M; Otsuji S; Tateyama H; Sakurai M; Awata N
    Circulation; 1999 Jul; 100(1):21-6. PubMed ID: 10393676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.
    Gershlick AH; Spriggins D; Davies SW; Syndercombe Court YD; Timmins J; Timmis AD; Rothman MT; Layton C; Balcon R
    Br Heart J; 1994 Jan; 71(1):7-15. PubMed ID: 8297699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fate of collateral vessels after successful coronary angioplasty in patients with effort angina.
    Fujita M; Nakae I; Fudo T; Tanaka T; Iwase T; Tamaki S; Nohara R; Sasayama S
    J Am Coll Cardiol; 1997 Mar; 29(3):544-8. PubMed ID: 9060891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Percutaneous transluminal coronary angioplasty and coronary bypass grafting for refractory angina in chronic dialysis patients].
    Takeshita S; Yamaguchi T; Isshiki T; Ikari Y; Maemura K; Furuta Y; Nagahara T; Suma H; Wanibuchi Y; Furuta S
    J Cardiol; 1992; 22(2-3):383-90. PubMed ID: 1339797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of repeat percutaneous transluminal coronary angioplasty for coronary restenosis.
    Williams DO; Gruentzig AR; Kent KM; Detre KM; Kelsey SF; To T
    Am J Cardiol; 1984 Jun; 53(12):32C-35C. PubMed ID: 6233884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enalapril for prevention of restenosis after coronary angioplasty.
    Kaul U; Chandra S; Bahl VK; Sharma S; Wasir HS
    Indian Heart J; 1993; 45(6):469-73. PubMed ID: 8070823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of vessel dilatation on restenosis after successful percutaneous transluminal coronary angioplasty.
    Schmitz HJ; Erbel R; Meyer J; von Essen R
    Am Heart J; 1996 May; 131(5):884-91. PubMed ID: 8615306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restenosis, reocclusion and adverse cardiovascular events after successful balloon angioplasty of occluded versus nonoccluded coronary arteries. Results from the Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR).
    Berger PB; Holmes DR; Ohman EM; O'Hanesian MA; Murphy JG; Schwartz RS; Serruys PW; Faxon DP
    J Am Coll Cardiol; 1996 Jan; 27(1):1-7. PubMed ID: 8522681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous transluminal coronary angioplasty after non-Q-wave acute myocardial infarction.
    Alfonso F; Macaya C; Iñiguez A; Bañuelos C; Fernandez-Ortiz A; Zarco P
    Am J Cardiol; 1990 Apr; 65(13):835-9. PubMed ID: 2321532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of coronary artery disease in non-dilated sites in the months following balloon angioplasty: time-dependent relation with restenosis.
    Benchimol D; Dartigues JF; Benchimol H; Bordier P; Duplàa C; Couffinhal T; Bonnet J
    Eur J Clin Invest; 1995 Dec; 25(12):935-41. PubMed ID: 8719934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.